Mach-1 Financial Group’s LifeMD LFMD Stock Holding History

Mach-1 Financial Group’s Portfolio LFMD Stock Details LFMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-23,808	Closed	-$324K	–	341
2025 Q2	$324K	Buy	+23,808	New	+$225K	0.09%	189

Other funds holding LFMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Mach-1 Financial Group's LFMD Position: Q3 2025 in Review

Mach-1 Financial Group sold out of LifeMD (LFMD) in Q3 2025, closing a stake of 23,808 shares — an estimated $324K sold.

Mach-1 Financial Group first reported a position in LFMD in Q2 2025 and held it in 1 quarter. The position peaked at $324K in Q2 2025. 114 funds tracked by Wall St. Rank hold LFMD as of Q3 2025.

Mach-1 Financial Group reported no remaining LifeMD position as of Q3 2025 after selling out during the quarter.
Mach-1 Financial Group sold 23,808 LifeMD shares in Q3 2025, an estimated $324K.
Mach-1 Financial Group first reported a position in LifeMD in Q2 2025 and held it in 1 quarter.
Mach-1 Financial Group's LifeMD position peaked at $324K in Q2 2025.
114 funds tracked by Wall St. Rank held LifeMD as of Q3 2025.

Based on Mach-1 Financial Group's 13F filing for Q3 2025, filed 12 Nov 2025.